Beaird Harris Wealth Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Beaird Harris Wealth Management’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7	Closed	-$29	–	629
2023 Q3	$29	Sell	7 -1	-13%	-$7	﹤0.01%	450
2023 Q2	$54	Hold	8	–	–	﹤0.01%	458
2023 Q1	$56	Hold	8	–	–	﹤0.01%	478
2022 Q4	$54	Sell	8 -7	-47%	-$59	﹤0.01%	730
2022 Q3	$0	Hold	15	–	–	﹤0.01%	546
2022 Q2	$0	Hold	15	–	–	﹤0.01%	658
2022 Q1	$1K	Hold	15	–	–	﹤0.01%	593
2021 Q4	$1K	Buy	+15	New	+$1.02K	﹤0.01%	640

Other funds holding HARP

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Beaird Harris Wealth Management's HARP Position: Q4 2023 in Review

Beaird Harris Wealth Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2023, closing a stake of 7 shares — an estimated $29 sold.

Beaird Harris Wealth Management first reported a position in HARP in Q4 2021 and held it in 8 quarters. The position peaked at $1K in Q1 2022. 41 funds tracked by Wall St. Rank hold HARP as of Q4 2023.

Beaird Harris Wealth Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Beaird Harris Wealth Management sold 7 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $29.
Beaird Harris Wealth Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Beaird Harris Wealth Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $1K in Q1 2022.
41 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Beaird Harris Wealth Management's 13F filing for Q4 2023, filed 27 Feb 2024.